Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Kimia Biosciences Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 530313 | NSE: Not Listed

Watchlist

NSE BSE

45.99

20-Dec-2024

Open
High
Low
Previous Close

47.98
47.98
43.51
47.98

Volume
Traded Value (lacs)
52 Week High
52 Week Low

12400
5.59
58.40
33.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

217.59
75.08
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

254.95
N/A
64.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

50.58
-0.27
-5.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-12.90
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

12.06
-
12.80

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

110.79
110.79
172.32

EV:EBITDA (Average)

8 Years
5 Years
3 Years

35.67
47.96
63.05

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 28.18 24.20 16.45% 22.40 24.23 -7.55% 30.30 22.66 33.72% 26.14 28.80 -9.24%
Expenses 24.81 26.16 -5.16% 18.69 25.87 -27.75% 26.14 28.03 -6.74% 27.19 31.76 -14.39%
EBITDA 3.37 -1.96 - 3.71 -1.64 - 4.17 -5.36 - -1.05 -2.95 -
EBIDTM 11.96% -8.10% 16.55% -6.76% 13.75% -23.67% -4.00% -10.25%
Other Income 0.37 0.64 -42.19% 0.08 0.13 -38.46% 0.30 0.36 -16.67% 0.58 0.26 123.08%
Interest 1.04 1.12 -7.14% 1.11 1.28 -13.28% 1.34 1.26 6.35% 1.31 1.05 24.76%
Depreciation 0.79 0.82 -3.66% 0.90 0.83 8.43% 0.82 0.87 -5.75% 0.82 0.84 -2.38%
PBT 1.92 -3.27 - 1.78 -3.62 - 2.31 -8.18 - -2.60 -4.58 -
Tax 0.30 -0.83 - 0.35 -0.91 - 0.51 -2.01 - -0.65 -1.12 -
PAT 1.61 -2.44 - 1.44 -2.71 - 1.80 -6.17 - -1.95 -3.46 -
PATM 5.73% -10.09% 6.42% -11.19% 5.93% -27.20% -7.47% -12.02%
EPS 0.34 -0.52 - 0.30 -0.57 - 0.38 -1.30 - -0.41 -0.73 -

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 107.02 104.88 128.52 124.90 132.71 106.29 93.92 76.31 1.46 0.19 1.75 Net Sales Growth 7.14% -18.39% 2.90% -5.89% 24.86% 13.17% 23.08% 5126.71% 668.42% -89.14% Cost Of Goods Sold 68.40 75.26 96.03 92.26 96.86 80.24 71.08 59.32 0.35 0.08 0.58 Gross Profit 38.62 29.62 32.48 32.64 35.86 26.04 22.84 16.99 1.11 0.11 1.17 GP Margin 36.08% 28.24% 25.27% 26.13% 27.02% 24.50% 24.32% 22.26% 76.03% 57.89% 66.86% Total Expenditure 96.83 105.36 133.61 124.27 124.33 101.83 88.34 73.83 2.44 3.57 3.66 Power & Fuel Cost - 5.25 7.29 6.54 4.54 3.21 2.54 1.85 0.17 0.31 0.66 % Of Sales - 5.01% 5.67% 5.24% 3.42% 3.02% 2.70% 2.42% 11.64% 163.16% 37.71% Employee Cost - 15.15 16.40 15.08 14.09 10.80 8.82 7.58 0.83 2.13 1.98 % Of Sales - 14.45% 12.76% 12.07% 10.62% 10.16% 9.39% 9.93% 56.85% 1121.05% 113.14% Manufacturing Exp. - 2.59 3.83 3.62 4.07 2.74 1.22 0.95 0.17 0.17 0.24 % Of Sales - 2.47% 2.98% 2.90% 3.07% 2.58% 1.30% 1.24% 11.64% 89.47% 13.71% General & Admin Exp. - 3.72 3.68 3.14 2.30 2.16 1.76 1.92 0.60 0.36 0.19 % Of Sales - 3.55% 2.86% 2.51% 1.73% 2.03% 1.87% 2.52% 41.10% 189.47% 10.86% Selling & Distn. Exp. - 1.92 2.47 1.80 1.15 0.94 0.57 0.40 0.01 0.01 0.01 % Of Sales - 1.83% 1.92% 1.44% 0.87% 0.88% 0.61% 0.52% 0.68% 5.26% 0.57% Miscellaneous Exp. - 1.47 3.92 1.82 1.33 1.74 2.36 1.82 0.30 0.51 0.01 % Of Sales - 1.40% 3.05% 1.46% 1.00% 1.64% 2.51% 2.39% 20.55% 268.42% 0% EBITDA 10.20 -0.48 -5.09 0.63 8.38 4.46 5.58 2.48 -0.98 -3.38 -1.91 EBITDA Margin 9.53% -0.46% -3.96% 0.50% 6.31% 4.20% 5.94% 3.25% -67.12% -1778.95% -109.14% Other Income 1.33 1.64 1.33 0.93 2.46 0.96 1.33 0.86 0.59 0.19 0.70 Interest 4.80 5.05 4.25 3.64 3.39 2.53 2.00 0.58 0.27 0.56 0.04 Depreciation 3.33 3.29 3.33 2.94 1.91 1.66 1.10 1.14 0.35 0.29 0.44 PBT 3.41 -7.18 -11.34 -5.02 5.53 1.23 3.81 1.60 -1.01 -4.04 -1.70 Tax 0.51 -1.88 -3.04 -1.32 0.43 -0.15 -0.05 -0.06 -0.08 0.01 0.01 Tax Rate 14.96% 26.18% 24.54% 26.29% 7.78% -12.20% -1.31% -3.75% 7.92% -0.25% -0.59% PAT 2.90 -5.31 -9.35 -3.70 5.10 1.38 3.86 1.67 -0.93 -4.05 -1.70 PAT before Minority Interest 2.90 -5.31 -9.35 -3.70 5.10 1.38 3.86 1.67 -0.93 -4.05 -1.70 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.71% -5.06% -7.28% -2.96% 3.84% 1.30% 4.11% 2.19% -63.70% -2131.58% -97.14% PAT Growth 119.62% - - - 269.57% -64.25% 131.14% - - - EPS 0.61 -1.12 -1.98 -0.78 1.08 0.29 0.82 0.35 -0.20 -0.86 -0.36

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 0.33 5.46 14.89 18.44 13.37 6.11 2.29 -4.61 -3.88 0.17 Share Capital 4.73 4.73 4.73 4.73 4.73 2.11 2.11 7.38 7.38 7.38 Total Reserves -4.40 0.73 10.16 13.71 8.64 2.03 -1.79 -12.00 -11.26 -7.21 Non-Current Liabilities 24.41 35.49 31.89 37.28 33.66 28.85 25.27 9.12 7.30 0.99 Secured Loans 4.44 6.45 3.89 9.75 8.70 0.62 0.28 0.00 2.91 0.04 Unsecured Loans 16.97 24.39 20.55 18.60 15.61 23.49 24.45 8.83 3.84 0.06 Long Term Provisions 1.45 1.45 1.12 1.17 0.88 0.64 0.49 0.29 0.27 0.40 Current Liabilities 69.44 76.40 61.80 50.95 38.63 30.44 30.69 7.24 0.68 3.46 Trade Payables 39.99 46.59 40.21 30.79 26.56 17.66 19.50 0.49 0.02 1.06 Other Current Liabilities 9.63 9.95 6.73 6.98 5.71 7.33 6.62 6.69 0.67 2.40 Short Term Borrowings 19.79 19.83 14.81 13.13 6.32 5.42 4.56 0.00 0.00 0.00 Short Term Provisions 0.03 0.03 0.05 0.05 0.04 0.03 0.01 0.06 0.00 0.00 Total Liabilities 94.18 117.35 108.58 106.67 85.66 65.40 58.25 11.75 4.10 4.62 Net Block 31.85 33.63 35.23 28.37 17.84 16.15 12.90 6.66 3.20 3.41 Gross Block 47.43 45.93 44.19 34.45 22.32 19.09 14.74 6.97 11.55 11.90 Accumulated Depreciation 15.59 12.30 8.96 6.08 4.47 2.94 1.84 0.31 8.34 8.49 Non Current Assets 32.77 34.60 35.51 34.83 24.72 17.85 15.49 9.86 3.50 3.71 Capital Work in Progress 0.58 0.61 0.00 5.77 5.74 1.53 2.48 3.07 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.34 0.24 0.20 0.66 1.13 0.17 0.12 0.13 0.14 0.14 Other Non Current Assets 0.02 0.12 0.08 0.03 0.00 0.00 0.00 0.00 0.15 0.16 Current Assets 61.41 82.75 73.07 70.14 60.95 47.55 42.76 1.88 0.61 0.92 Current Investments 0.00 0.06 0.06 0.06 0.42 0.01 0.00 0.00 0.00 0.00 Inventories 30.80 48.23 37.02 23.69 20.31 16.10 9.59 0.59 0.07 0.08 Sundry Debtors 27.55 30.59 30.20 41.77 37.33 29.12 29.50 0.08 0.09 0.27 Cash & Bank 0.53 0.50 0.52 1.67 0.77 1.26 2.03 0.07 0.01 0.00 Other Current Assets 2.52 1.84 1.02 1.90 2.12 1.05 1.64 1.14 0.43 0.56 Short Term Loans & Adv. 1.56 1.53 4.26 1.06 0.94 0.82 1.39 0.44 0.39 0.56 Net Current Assets -8.03 6.35 11.27 19.19 22.32 17.11 12.07 -5.36 -0.08 -2.54 Total Assets 94.18 117.35 108.58 104.97 85.67 65.40 58.25 11.74 4.11 4.63

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 14.53 -6.77 8.00 5.97 0.31 -2.65 -7.09 -0.74 -5.99 0.04 PBT -7.18 -12.39 -5.02 5.53 1.23 3.81 1.60 -1.01 -4.04 -1.70 Adjustment 7.76 7.60 5.96 3.57 3.81 1.35 1.36 0.77 0.86 0.49 Changes in Working Capital 13.94 -2.00 7.13 -3.18 -4.80 -7.65 -10.06 -0.47 -2.80 1.25 Cash after chg. in Working capital 14.51 -6.78 8.07 5.92 0.24 -2.49 -7.10 -0.70 -5.99 0.04 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.03 0.01 -0.07 0.04 0.07 -0.16 0.01 -0.04 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.49 -2.80 -0.71 -13.60 -8.63 -2.22 -2.36 -6.23 -0.10 0.01 Net Fixed Assets -1.47 -2.35 -3.97 -12.16 -7.44 -3.40 -7.18 1.51 0.35 0.04 Net Investments 0.06 0.00 0.00 0.36 -0.41 -0.01 0.00 0.00 0.00 0.00 Others -0.08 -0.45 3.26 -1.80 -0.78 1.19 4.82 -7.74 -0.45 -0.03 Cash from Financing Activity -13.07 9.54 -7.67 7.99 8.46 4.42 9.91 7.01 6.09 -0.06 Net Cash Inflow / Outflow -0.03 -0.03 -0.38 0.35 0.14 -0.46 0.46 0.04 0.01 -0.01 Opening Cash & Equivalents 0.18 0.20 0.59 0.23 0.09 0.55 0.09 0.01 0.00 0.02 Closing Cash & Equivalent 0.15 0.18 0.20 0.59 0.23 0.09 0.55 0.05 0.01 0.00

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 0.07 1.15 3.15 3.90 2.86 2.39 -0.23 -6.25 -5.25 0.24 ROA -5.02% -8.28% -3.44% 5.31% 1.83% 6.24% 4.76% -11.72% -92.83% -33.62% ROE -183.25% -91.91% -22.22% 32.19% 16.47% 243.83% 0.00% 0.00% 0.00% -166.09% ROCE -4.18% -14.30% -2.32% 16.13% 8.94% 16.94% 11.83% -18.30% -216.82% -135.77% Fixed Asset Turnover 2.25 2.85 3.18 4.68 5.13 5.55 7.04 0.16 0.02 0.15 Receivable days 101.18 86.33 105.16 108.76 114.09 113.91 70.58 20.80 345.52 68.50 Inventory Days 137.54 121.06 88.70 60.51 62.52 49.92 24.31 83.49 143.48 15.13 Payable days 209.95 164.94 140.43 108.06 100.58 79.39 49.73 48.83 64.75 91.70 Cash Conversion Cycle 28.76 42.45 53.43 61.21 76.04 84.43 45.15 55.46 424.25 -8.07 Total Debt/Equity 131.12 9.69 2.73 2.44 2.54 7.39 91.22 -2.12 -1.74 1.00 Interest Cover -0.42 -1.92 -0.38 2.63 1.48 2.91 3.76 -2.74 -6.26 -40.97

Top Investors:

anish kumar aggarwal

Annual Reports:

News Update:

Kimia Biosciences bags contact worth $200,000
16th Sep 2024, 17:23 PM

The contract is related to Contract development and manufacturing organization
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback